Kunihiko Hinohara
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Fatty acid amide hydrolase inhibition for treatment of amyotrophic lateral sclerosis.
Journal: JCI insight
Published: August 11, 2025
Dysregulated synaptic gene expression in oligodendrocytes of spinal and bulbar muscular atrophy.
Journal: JCI insight
Published: April 22, 2024
Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade.
Journal: British journal of cancer
Published: November 29, 2023
Genetic background variation impacts microglial heterogeneity and disease progression in amyotrophic lateral sclerosis model mice.
Journal: iScience
Published: June 12, 2023
Heterogeneity and transcriptional drivers of triple-negative breast cancer.
Journal: Cell reports
Published: June 01, 2023
Cancer Phenotypic Plasticity and Therapeutic Resistance
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: February 10, 2023
Significance of regulatory T cells in cancer immunology and immunotherapy.
Journal: Experimental dermatology
Published: October 31, 2022
The cancer epigenome: Non-cell autonomous player in tumor immunity.
Journal: Cancer science
Published: October 25, 2022
BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state.
Journal: Nature communications
Published: July 28, 2022
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer.
Journal: Nature communications
Published: February 06, 2022
Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal.
Journal: Journal for immunotherapy of cancer
Published: July 26, 2021
Last Updated: 09/26/2026